TY  - GEN
AU  - Layton,A M
AU  - Schaller,M
AU  - Homey,B
AU  - Hofmann,M A
AU  - Bewley,A P
AU  - Lehmann,P
AU  - Nohlgård,C
AU  - Sarwer,D B
AU  - Kerrouche,N
AU  - Ma,Y M
TI  - Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study
SN  - 1468-3083
PY  - 2016///1014
KW  - Adrenergic alpha-2 Receptor Agonists
KW  - adverse effects
KW  - Adult
KW  - Aged
KW  - Brimonidine Tartrate
KW  - Erythema
KW  - drug therapy
KW  - Facial Dermatoses
KW  - Female
KW  - Gels
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Patient Satisfaction
KW  - Rosacea
KW  - complications
KW  - Severity of Illness Index
KW  - Surveys and Questionnaires
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/jdv.13305
ER  -